Madiha Nooreen, Shafia Fatima, R. Nagarapu, M. Khan, A. Khan
{"title":"Genetic Determinants Involved in the Osteoporosis Pathophysiology","authors":"Madiha Nooreen, Shafia Fatima, R. Nagarapu, M. Khan, A. Khan","doi":"10.2174/1875692117999201211143315","DOIUrl":null,"url":null,"abstract":"\n\nOsteoporosis is a chronic disease characterized by decreased bone mass and\ndistorted microarchitecture that leads to increased bone fragility making an individual\nprone to fractures. It is one of the most widely affected diseases worldwide that has the\npotential to cause serious morbidity, mortality and cost implications. It is a multifactorial\ndisease that is influenced by the interaction between genetic, hormonal, nutritional and\nenvironmental factors. As it is a polygenic disorder, myriad genes influence the disease\ncondition to a varied extent. The identification of genes or loci that effects the development\nof the disease will help not only in individualizing the prognosis, treatment and prevention\nof fractures but also in discovering novel therapeutic agents. The genetic association\nstudies on osteoporosis have reported conflicting results. Well designed and efficiently\nconducted studies with enough power to detect variations in the interaction between\nvarious contributing factors of the disease in the homogenous population are needed to establish\nconclusive genotypic associations with the disease. The present review briefly\nsummarizes the data published on the genes affecting osteoporosis development.\n","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"48 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pharmacogenomics and Personalized Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1875692117999201211143315","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 1
Abstract
Osteoporosis is a chronic disease characterized by decreased bone mass and
distorted microarchitecture that leads to increased bone fragility making an individual
prone to fractures. It is one of the most widely affected diseases worldwide that has the
potential to cause serious morbidity, mortality and cost implications. It is a multifactorial
disease that is influenced by the interaction between genetic, hormonal, nutritional and
environmental factors. As it is a polygenic disorder, myriad genes influence the disease
condition to a varied extent. The identification of genes or loci that effects the development
of the disease will help not only in individualizing the prognosis, treatment and prevention
of fractures but also in discovering novel therapeutic agents. The genetic association
studies on osteoporosis have reported conflicting results. Well designed and efficiently
conducted studies with enough power to detect variations in the interaction between
various contributing factors of the disease in the homogenous population are needed to establish
conclusive genotypic associations with the disease. The present review briefly
summarizes the data published on the genes affecting osteoporosis development.
期刊介绍:
Current Pharmacogenomics and Personalized Medicine (Formerly ‘Current Pharmacogenomics’) Current Pharmacogenomics and Personalized Medicine (CPPM) is an international peer reviewed biomedical journal that publishes expert reviews, and state of the art analyses on all aspects of pharmacogenomics and personalized medicine under a single cover. The CPPM addresses the complex transdisciplinary challenges and promises emerging from the fusion of knowledge domains in therapeutics and diagnostics (i.e., theragnostics). The journal bears in mind the increasingly globalized nature of health research and services.